ACE2 and COVID-19: The close relationship between the mechanism of SARS-CoV-2 entry into the cells, ACE2, and the significant number of patients affected by COVID-19 with comorbidities requiring use of RAAS modulators, presents a conundrum that can only be solved by focused clinical studies.